Helixmith Co., Ltd

KOSDAQ:A084990 Stock Report

Market Cap: ₩138.1b

Helixmith Past Earnings Performance

Past criteria checks 0/6

Helixmith has been growing earnings at an average annual rate of 17.7%, while the Biotechs industry saw earnings growing at 2.7% annually. Revenues have been declining at an average rate of 4.5% per year.

Key information

17.7%

Earnings growth rate

25.8%

EPS growth rate

Biotechs Industry Growth11.7%
Revenue growth rate-4.5%
Return on equity-34.8%
Net Margin-1,287.2%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Helixmith (KOSDAQ:084990) Is In A Good Position To Deliver On Growth Plans

Oct 18
Helixmith (KOSDAQ:084990) Is In A Good Position To Deliver On Growth Plans

Would Shareholders Who Purchased Helixmith's (KOSDAQ:084990) Stock Three Years Be Happy With The Share price Today?

Feb 19
Would Shareholders Who Purchased Helixmith's (KOSDAQ:084990) Stock Three Years Be Happy With The Share price Today?

Revenue & Expenses Breakdown

How Helixmith makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

KOSDAQ:A084990 Revenue, expenses and earnings (KRW Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 243,880-49,93913,7459,161
30 Jun 243,169-54,42314,71810,858
31 Mar 243,548-58,62815,36513,964
31 Dec 234,202-64,08818,84417,145
30 Sep 234,415-38,21418,47124,101
30 Jun 234,092-41,01521,35826,438
31 Mar 233,497-42,09922,91028,389
31 Dec 222,800-43,53823,29928,101
30 Sep 222,892-55,43424,99430,804
30 Jun 222,774-48,65023,47128,588
31 Mar 222,701-61,86323,52125,752
31 Dec 212,316-66,00523,00025,297
30 Sep 212,430-43,72915,51422,522
30 Jun 212,737-55,09817,84724,439
31 Mar 213,799-57,43221,02035,574
31 Dec 204,248-65,38019,03137,419
30 Sep 204,967-159,38620,37340,511
30 Jun 205,367-153,31319,96337,009
31 Mar 204,827-114,48816,67526,082
31 Dec 194,455-106,88517,20221,474
30 Sep 193,653-29,88823,88510,631
30 Jun 193,015-26,22921,4819,769
31 Mar 193,119-41,93917,9797,490
31 Dec 183,127-27,40314,2596,390
30 Sep 183,154-13,25310,1685,739
30 Jun 183,268-8,2636,8874,914
31 Mar 183,235-7,1895,8484,106
31 Dec 173,158-6,4965,4533,845
30 Sep 145,205-2,6104,311478
30 Jun 145,484-8424,199381
31 Mar 145,394-904,056452
31 Dec 135,7462663,954438

Quality Earnings: A084990 is currently unprofitable.

Growing Profit Margin: A084990 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: A084990 is unprofitable, but has reduced losses over the past 5 years at a rate of 17.7% per year.

Accelerating Growth: Unable to compare A084990's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: A084990 is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (7.9%).


Return on Equity

High ROE: A084990 has a negative Return on Equity (-34.84%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies